Can a simple genetic test get more people on heart-saving statins?

This study looks at whether giving patients and their doctors a polygenic risk score — a genetic test that estimates future risk of coronary heart disease — helps more people start taking statins to prevent heart problems. Researchers will enroll 200 adults aged 40-69 without prior heart disease or statin use from rural and urban clinics. Half will get the genetic risk score along with standard risk assessment; the other half will get standard assessment alone. The main goal is to see if the genetic information leads to more statin prescriptions and lower cholesterol.